Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A multicenter, phase I/II trial of anastrozole, palbociclib, trastuzumab, and pertuzumab in hormone receptor (HR)-positive, HER2-positive metastatic breast cancer (ASPIRE).
Journal: Journal of the National Cancer Institute
Published: March 24, 2026
Randomized phase II comparison of single-agent carboplatin versus combination of carboplatin and everolimus for advanced triple negative breast cancer.
Journal: Breast cancer research and treatment
Published: May 16, 2025
Monitoring of estradiol levels in premenopausal women receiving adjuvant abemaciclib and ovarian function suppression.
Journal: Breast cancer research and treatment
Published: May 19, 2024
Discrepancies in estradiol levels in a premenopausal woman receiving abemaciclib despite ovarian function suppression and bilateral salpingo-oophorectomy.
Journal: Current problems in cancer. Case reports
Published: May 01, 2023
Optimism and coping: do they influence health outcomes in women with breast cancer? A systemic review and meta-analysis.
Journal: Breast cancer research and treatment
Published: March 10, 2020
Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 31, 2014
A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer.
Journal: Clinical breast cancer
Published: September 13, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026